Company Filing History:
Years Active: 2022-2025
Title: Peter Bunyard: Innovator in Rho-Associated Protein Kinase Modulation
Introduction
Peter Bunyard is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of Rho-associated protein kinases. With a total of 3 patents to his name, Bunyard's work is paving the way for new treatments in various medical conditions.
Latest Patents
Among his latest patents, Bunyard has developed novel compounds and pharmaceutical compositions that serve as modulators of Rho-associated protein kinase (ROCK). These compounds are specifically designed to inhibit ROCK1 and/or ROCK2, which are crucial in treating ROCK-mediated diseases. The methods of treatment employing these compounds are also a significant aspect of his inventions, showcasing their potential in therapeutic applications.
Career Highlights
Bunyard is currently associated with Redx Pharma Limited, where he continues to innovate and contribute to the pharmaceutical industry. His expertise in the modulation of protein kinases has positioned him as a key figure in the development of new therapeutic strategies.
Collaborations
Throughout his career, Bunyard has collaborated with notable colleagues, including Gary Pitt and Liam Byrne. These partnerships have enhanced his research and development efforts, leading to impactful innovations in the field.
Conclusion
Peter Bunyard's work in the modulation of Rho-associated protein kinases represents a significant advancement in pharmaceutical research. His contributions are vital for the development of new treatments for diseases mediated by these proteins.